metoprolol has been researched along with Granulocytic Leukemia, Chronic in 1 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Y | 1 |
| Zhou, L | 1 |
| Dutreix, C | 1 |
| Leroy, E | 1 |
| Yin, Q | 1 |
| Sethuraman, V | 1 |
| Riviere, GJ | 1 |
| Yin, OQ | 1 |
| Schran, H | 1 |
| Shen, ZX | 1 |
1 other study available for metoprolol and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Effects of imatinib (Glivec) on the pharmacokinetics of metoprolol, a CYP2D6 substrate, in Chinese patients with chronic myelogenous leukaemia.
Topics: Adrenergic beta-Antagonists; Adult; Antineoplastic Agents; Asian People; Benzamides; Cytochrome P-45 | 2008 |